Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37636
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRichard Kitching A.en
dc.contributor.authorHoldsworth S.R.en
dc.contributor.authorDick J.en
dc.contributor.authorGan P.-Y.en
dc.date.accessioned2021-05-14T12:48:39Zen
dc.date.available2021-05-14T12:48:39Zen
dc.date.copyright2018en
dc.date.created20180117en
dc.date.issued2018-01-17en
dc.identifier.citationPLoS ONE. 13 (1) (no pagination), 2018. Article Number: e0190655. Date of Publication: January 2018.en
dc.identifier.issn1932-6203 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/37636en
dc.description.abstractThe anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides are autoimmune diseases associated with significant morbidity and mortality. They often affect the kidney causing rapidly progressive glomerulonephritis. While signalling by complement anaphylatoxin C5a though the C5a receptor is important in this disease, the role of the anaphylatoxin C3a signalling via the C3a receptor (C3aR) is not known. Using two different murine models of anti-myeloperoxidase (MPO) glomerulonephritis, one mediated by passive transfer of anti-MPO antibodies, the other by cell-mediated immunity, we found that the C3aR did not alter histological disease severity. However, it promoted macrophage recruitment to the inflamed glomerulus and inhibited the generation of MPO-ANCA whilst not influencing T cell autoimmunity. Thus, whilst the C3aR modulates some elements of disease pathogenesis, overall it is not critical in effector responses and glomerular injury caused by autoimmunity to MPO.Copyright © 2018 Dick et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.languageenen
dc.languageEnglishen
dc.publisherPublic Library of Science (E-mail: plos@plos.org)en
dc.relation.ispartofPLoS ONEen
dc.titleThe c3ar promotes macrophage infiltration and regulates anca production but does not affect glomerular injury in experimental antimyeloperoxidase glomerulonephritis.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1371/journal.pone.0190655en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid29315316 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29315316]en
dc.identifier.source620133318en
dc.identifier.institution(Dick, Gan, Richard Kitching, Holdsworth) Centre for Inflammatory Diseases, Monash University, Department of Medicine, Clayton, VIC, Australia (Dick, Richard Kitching, Holdsworth) Department of Nephrology, Monash Health, Clayton, VIC, Australia (Richard Kitching) Department of Paediatric Nephrology, Monash Children's Hospital, Monash Health, Clayton, VIC, Australiaen
dc.description.addressS.R. Holdsworth, Centre for Inflammatory Diseases, Monash University, Department of Medicine, Clayton, VIC, Australia. E-mail: Stephen.Holdsworth@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2018 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailHoldsworth S.R.; Stephen.Holdsworth@monash.eduen
dc.description.grantNo: 1046585 Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australia No: 1075803 Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australiaen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptImmunology and Allergy-
Appears in Collections:Articles
Show simple item record

Page view(s)

32
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.